Absci (ABSI) Research & Development (2020 - 2026)

Absci (ABSI) has 7 years of Research & Development data on file, last reported at $19.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 17.79% year-over-year to $19.3 million; the trailing twelve-month figure through Mar 2026 stood at $84.3 million (up 24.04% YoY), and the FY2025 full-year result was $81.4 million, up 27.5% from the prior year.
• Research & Development declined to $19.3 million in Q1 2026, from $25.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $25.3 million in Q4 2025 to a low of $11.0 million in Q3 2023.
• A 5-year average of $16.0 million and a median of $15.8 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 124.5% in 2022 and decreased 28.96% in 2023, its largest moves.
• Tracing ABSI's Research & Development over 5 years: stood at $11.3 million in 2022, then rose by 8.43% to $12.3 million in 2023, then soared by 49.78% to $18.4 million in 2024, then soared by 37.93% to $25.3 million in 2025, then decreased by 23.96% to $19.3 million in 2026.
• Business Quant data shows ABSI's Research & Development at $19.3 million in Q1 2026, $25.3 million in Q4 2025, and $19.2 million in Q3 2025.